Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$55.06 - $69.99 $688,250 - $874,874
12,500 Added 82.24%
27,700 $1.55 Million
Q4 2023

Feb 14, 2024

BUY
$57.25 - $69.74 $51,525 - $62,765
900 Added 6.29%
15,200 $915,000
Q3 2023

Nov 14, 2023

BUY
$63.16 - $76.5 $852,660 - $1.03 Million
13,500 Added 1687.5%
14,300 $961,000
Q2 2023

Aug 14, 2023

BUY
$46.28 - $75.01 $37,024 - $60,008
800 New
800 $55,000

Others Institutions Holding LEGN

About Legend Biotech Corp


  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $6.73B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track Aquatic Capital Management LLC Portfolio

Follow Aquatic Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aquatic Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aquatic Capital Management LLC with notifications on news.